70% of clinical trials exclude patients with comorbidities, even though 70% of real-world patients have multiple conditions. Our CEO @BrighamHyde explores how AI-driven real-world evidence helps P&T committees build a precision formulary: pharmabusinessoutlook.com/building-a-pre… #healthcareAI
Atropos Health
@AtroposHealth
Generating publication-grade real-world evidence in minutes to days for precision medicine and clinical decision support.
172 Following 238 Followers 410 Posts
Latest posts 5
We’re at Booth 101 at #ISPOREurope, steps from the coffee station. Grab a cup and bring us a complex clinical question. We’ll show you how to run an auditable, publication-grade observational study, live. #HEOR #RWE @ISPORorg
Next week, we’re at @BeckersHR Fall Chief Pharmacy Officer Summit in Chicago. Stop by booth #200 to see how formulary and P&T teams run comparative effectiveness studies on their own patient data in minutes. #Pharmacy #RealWorldEvidence #HealthcareAI
70% of U.S. patients live with at least one comorbidity. And still, 70% of clinical trials exclude them.
In a recent interview with Business Insight Journal, @BrighamHyde breaks down why this gap persists, and how #RealWorldEvidence closes it: bi-journal.com/business-insig…
In a recent interview with Business Insight Journal, @BrighamHyde breaks down why this gap persists, and how #RealWorldEvidence closes it: bi-journal.com/business-insig…
A "normal" blood test can still predict disease a decade out.
That's one finding from a new @NatImmunol paper on neutrophils, the most common immune cell in your blood: nature.com/articles/s4159… 🧵
That's one finding from a new @NatImmunol paper on neutrophils, the most common immune cell in your blood: nature.com/articles/s4159… 🧵